Bookmark and Share
glycogen synthase kinase-3 beta isoform 1 [Ho.. [gi:21361340] - Target BioActivity Data
Also known as: glycogen synthase kinase-3 beta isoform 1 [Homo sapiens].
Filters: All Data » Active      
Filter selected
BioActivity Outcomes:
Active(891)
 
 
BioAssay Types:
Confirmatory(737)
 
 
Screening(116)
 
 
BioActivity Types:
EC50(581)
 
 
AC50(156)
 
 
Substance Types:
Chemical(891)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 10    Data Row: 891   Total Pages: 18   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayLinks
OutcomeTypeValue [μM]
1
[SID104170299]
[CID6539118]
AC50_uM 0.0113Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2 [AID623989, Type: confirmatory]
View
2
[SID104170299]
[CID6539118]
AC50_uM 0.0124Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588429, Type: confirmatory]
View
3
[SID135378270]
[CID5524264]
AC50_uM 0.0126GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
4
[SID134216526]
[CID56589437]
AC50_uM 0.0132GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
5
[SID103023249]
[CID661958]
AC50_uM 0.016Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588429, Type: confirmatory]
View
6
[SID103023235]
[CID46500289]
AC50_uM 0.016Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588429, Type: confirmatory]
View
7
[SID103023240]
[CID9558362]
AC50_uM 0.016Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2 [AID623989, Type: confirmatory]
View
8
[SID87219187]
[CID6539118]
AC50_uM 0.016Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588429, Type: confirmatory]
View
9
[SID134970446]
AC50_uM 0.0238GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
10
[SID87219187]
[CID6539118]
AC50_uM 0.03Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2 [AID623989, Type: confirmatory]
View
11
[SID135378258]
[CID56846679]
AC50_uM 0.0324GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
12
[SID135378282]
[CID56846668]
AC50_uM 0.0357GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
13
[SID103023211]
[CID936046]
AC50_uM 0.036Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2 [AID623989, Type: confirmatory]
View
14
[SID134970447]
[CID56840724]
AC50_uM 0.037GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
15
[SID134959048]
[CID57417014]
AC50_uM 0.041GSK3beta Assay at Varied ATP concentrations Measured in Biochemical System Using Plate Reader - 2046-04_Inhibitor_Dose_DryPowder_Activity [AID624027, Type: confirmatory]
View
16
[SID134216517]
[CID56589435]
AC50_uM 0.0425GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
17
[SID134216538]
[CID5344074]
AC50_uM 0.0452GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
18
[SID135378275]
[CID5523858]
AC50_uM 0.0472GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
19
[SID135378278]
[CID56846665]
AC50_uM 0.05GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
20
[SID135378276]
[CID56846680]
AC50_uM 0.0513GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
21
[SID135378252]
[CID56846667]
AC50_uM 0.0523GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
22
[SID124360055]
[CID3541811]
AC50_uM 0.0544Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity [AID588406, Type: confirmatory]
View
23
[SID124360050]
[CID899976]
AC50_uM 0.068Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity [AID588406, Type: confirmatory]
View
24
[SID26731878]
[CID16746083]
EC50_uM 0.0779Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity [AID434954, Type: confirmatory]
View
25
[SID134216523]
[CID56589411]
AC50_uM 0.0833GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
26
[SID135378255]
[CID56846676]
AC50_uM 0.0875GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
27
[SID103023248]
[CID5727763]
AC50_uM 0.095Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588429, Type: confirmatory]
View
28
[SID864187]
[CID665435]
EC50_uM 0.0951Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity [AID434954, Type: confirmatory]
View
29
[SID135378282]
[CID56846668]
AC50_uM 0.103GSK3beta Assay at Varied ATP concentrations Measured in Biochemical System Using Plate Reader - 2046-04_Inhibitor_Dose_DryPowder_Activity [AID624027, Type: confirmatory]
View
30
[SID49735230]
[CID9558362]
EC50_uM 0.1048Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity [AID434954, Type: confirmatory]
View
31
[SID103023246]
[CID10114110]
AC50_uM 0.107Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2 [AID623989, Type: confirmatory]
View
32
[SID49716136]
[CID9636042]
EC50_uM 0.1157Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity [AID434954, Type: confirmatory]
View
33
[SID134216525]
[CID56589405]
AC50_uM 0.122GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
34
[SID135378292]
[CID5928898]
AC50_uM 0.124GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
35
[SID134959049]
[CID56589437]
AC50_uM 0.128GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
36
[SID135378268]
[CID5830978]
AC50_uM 0.133GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
37
[SID135378253]
[CID56846661]
AC50_uM 0.134GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
38
[SID103023202]
[CID3294594]
AC50_uM 0.134Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588429, Type: confirmatory]
View
39
[SID134970446]
AC50_uM 0.143GSK3beta Assay at Varied ATP concentrations Measured in Biochemical System Using Plate Reader - 2046-04_Inhibitor_Dose_DryPowder_Activity [AID624027, Type: confirmatory]
View
40
[SID124360049]
[CID934473]
AC50_uM 0.143Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity [AID588406, Type: confirmatory]
View
41
[SID103023218]
[CID49766509]
AC50_uM 0.161Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588429, Type: confirmatory]
View
42
[SID26671626]
[CID936046]
EC50_uM 0.1713Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity [AID434954, Type: confirmatory]
View
43
[SID135378261]
[CID56846657]
AC50_uM 0.173GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
44
[SID860681]
[CID661958]
EC50_uM 0.1737Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity [AID434954, Type: confirmatory]
View
45
[SID47204432]
[CID6877491]
EC50_uM 0.1765Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity [AID434954, Type: confirmatory]
View
46
[SID135378262]
[CID56846653]
AC50_uM 0.18GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
47
[SID49667187]
[CID6151638]
EC50_uM 0.181Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity [AID434954, Type: confirmatory]
View
48
[SID135378283]
[CID56846660]
AC50_uM 0.184GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_Activity [AID623998, Type: confirmatory]
View
49
[SID49829343]
[CID5857882]
EC50_uM 0.1864Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity [AID434954, Type: confirmatory]
View
50
[SID103023239]
[CID9666997]
AC50_uM 0.197Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2 [AID623989, Type: confirmatory]
View